← Open Payments lookup

MARCO GABBAI: Open Payments

NPI 1073983482 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$659 in 21 payments from 8 companies in 2025. Trend: 2023 $56 · 2024 $446 · 2025 $659

Food & beverage: $659
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$154
AstraZeneca Pharmaceuticals LP2$147
Novartis Pharmaceuticals Corporation5$89
SCPHARMACEUTICALS INC.3$87
E.R. Squibb & Sons, L.L.C.4$78
Bayer Healthcare Pharmaceuticals Inc.2$51
PFIZER INC.2$38
Merck Sharp & Dohme LLC1$16

Products named: JARDIANCE, LOKELMA, LEQVIO, FUROSCIX, ELIQUIS, Kerendia, CAMZYOS, FARXIGA.

Industry payments across MD — which companies pay providers there.